GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.16
Bid: 3.52
Ask: 4.80
Change: 0.16 (4.00%)
Spread: 1.28 (36.364%)
Open: 4.00
High: 0.00
Low: 0.00
Prev. Close: 4.00
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK SMALLCAP ROUNDUP: African Minerals Gets $1.5B For Tonkolili

Tue, 13th Jul 2010 09:30

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps AFRICAN MINERALS LTD. (AMI.LN), an iron ore miner focused on Sierra Leone, Tuesday said it agreed a $1.5 billion investment in its Tonkolili project from Shandong Iron & Steel Group Co., in a deal that underscores China's appetite for raw materials to fuel its economic expansion. At 0804 GMT, shares +55.25 pence, or 14%, at 440.25 pence. INVISTA FOUNDATION PROPERTY TRUST LTD. (IFD.LN), a real estate investor, said it launched a share sale to strengthen its balance sheet and fund acquisitions. Invista said it intends to issue up to 32.3 million new shares to institutional investors in a type of share auction called a bookbuild. At 0804 GMT, shares +0.25 pence, or 0.6%, at 40.25 pence. MONITISE PLC (MONI.LN), a developer of banking services for mobile phones, said it is to raise GBP32.4 million through a share sale and announced an improved strategic partnership with Visa Inc. (V). At 0804 GMT, shares +1.75 pence, or 8.3%, at 22.75 pence. DUNELM GROUP PLC (DNLM.LN), a homeware retailer, said comparable sales growth slowed in its second half, and was marginally negative in the final ten weeks of the fiscal, although it expects full-year operating profit to be slightly higher than market expectations. At 0803 GMT, shares +13 pence, or 3.6%, at 371 pence. LUMINAR GROUP HOLDINGS PLC (LMR.LN), a nightclub operator, said the recent soccer World Cup tournament dented sales in its most recent 19 weeks' trading, with comparable sales plunging 19.9% in the period. At 0803 GMT, shares -1.5 pence, or 13%, at 10 pence. BTG PLC (BGC.LN), a pharmaceutical company, said it is putting the finishing touches on its plans to begin selling two emergency medicines in October. BTG acquired the rights to snake venom antidote CroFab and digoxin poisoning treatment DigiFab when it bought biotech peer Protherics PLC in 2008. BTG said it has hired senior sales and marketing staff, secured distributors and expects to have all the necessary sales licenses in place by August. At 0803 GMT, shares -1.3 pence, or 0.7%, at 200 pence. ARK THERAPEUTICS GROUP PLC (AKT.LN), a biotechnology company, said it is in talks with potential buyers of its wound care business. The company, which launched a strategic review after its experimental brain cancer medicine Cerepro was rejected by European drug regulators earlier this year, said a number of companies are completing due diligence on its wound care unit and negotiations are in progress. It added it is also in talks with potential strategic partners keen to make use of its Finland-based manufacturing facilities and said it is drawing up a plan for a U.S. clinical trial of Cerepro and is seeking a partner to pay for it. At 0802 GMT, shares flat at 4.88 pence. LOW & BONAR PLC (LWB.LN), a supplier of yarns and fabrics, reintroduced an interim dividend following a swing to a first-half pretax profit on the continued improvement in sales. At 0802 GMT, shares -5 pence, or 12%, at 38 pence. PROTEOME SCIENCES PLC (PRM.LN), a diagnostics company, said it developed two tests focused on aspects of Alzheimer's disease. At 0802 GMT, shares flat at 21.75 pence. INDIAN ENERGY LTD. (IEL.LN), a developer of wind farms in India, reported a wider fiscal-year loss due to the cost of joining the stock market, and said it is on track to hitting its target of being able to generate 300 megawatts of electricity by 2013. The company said it is evaluating new projects. Indian Energy added it agreed a GBP2 million loan from shareholder Utilico Emerging Markets Ltd. (UEM.LN) to pay for options on new wind projects. It said it is looking at ways to raise extra capital. At 0809 GMT, shares -4.25 pence, or 8.8%, at 44 pence. DTZ HOLDINGS PLC (DTZ.LN), a property consultant, posted a narrower fiscal-year loss following its strategic review and restructuring program, and said it plans to buy the remaining 20% stake of DTZ Asset Management Europe SAS that it doesn't already own. At 0809 GMT, shares +2 pence, or 3.3%, at 62.5 pence. DJ UK Smaller Cos +0.1% AIM +0.5% -By Jason Douglas, Hannah Benjamin and Rachael Gormley, Dow Jones Newswires; +44 (0) 20 7842 9272; uksmallcaps@dowjones.com (END) Dow Jones Newswires July 13, 2010 04:30 ET (08:30 GMT)
More News
20 Nov 2013 07:52

AIM IN BRIEF: Rangers FC Appoints Graham Wallace As CEO

Read more
30 Sep 2013 09:26

Proteome Sciences Losses Widen Despite Revenue Growth; Signs USD2.1M Contract

Read more
18 Sep 2013 15:03

Proteome Expects Strong Second-Half Growth After Making Alzheimer's Progress

Read more
12 Jun 2013 11:37

Proteome Sciences to develop cancer pathway profiling assays

AIM-listed biotech group Proteome Sciences has unveiled its largest contract to date comprising a technology agreement with Thermo Fisher Scientific, to develop advanced methods to profile changes in cancer pathways. Proteome Sciences said that the contract - which it valued at £2.1m - would prov

Read more
18 Mar 2013 14:29

Proteome Sciences looks ahead with confidence

Drug developer Proteome Sciences has told investors that it expects strong revenue growth across the company's three main divisions in 2013 and said it is 'much encouraged by the prospects'. The announcement comes after the group received a positive response to the presentation of four posters tha

Read more
31 Dec 2012 12:50

STOCKS NEWS EUROPE-UK small caps closes modestly higher

The FTSE Small Caps index closes 0.1 percent higher on Monday, New Year's Eve, tracking similar modest gains by the mid caps, also up 0.1 percent, while the blue chips shed 0.5 percent after a half-day session. The small caps index has gained 24 percent over 2012, just outperforming a 22 percent adv

Read more
31 Dec 2012 10:48

Proteome delivers encouraging results from Alzheimers study

Drug maker Proteome Sciences has completed the in-vivo study of its CK1D inhibitor programme in Alzheimer's disease on time, with the results showing that both of the lead compounds for CK1D demonstrated improved cognitive function. The firm said the results provide important in-vivo proof of prin

Read more
28 Sep 2012 10:46

Proteome Sciences narrows losses, bright outlook

Proteomics specialist Proteome Sciences reduced half year losses and expects second half revenues to be significantly boosted as it doubles the number of biomarker tests available from PS Biomarker Services. The group expects major licences and contracts from its proprietary biomarkers and services

Read more
18 Sep 2012 10:57

Proteome stroke test could save thousands from brain damage

Medical technology group Proteome Sciences has released details of a study into a blood test which could reduce brain damage in thousands of stroke victims. The group has been collaborating with researchers at the University of Geneva to produce the test which can tell how long ago a stroke actuall

Read more
20 Aug 2012 07:43

London pre-open: Doubts about further Chinese stimulus

City sources predict the FTSE 100 will open up five points from Friday's close of 5,852, having gained 18 points during Friday's session following positive data from the US. Over the weekend it was reported in Europe by the Handelsblatt newspaper that the European Union could appoint the European

Read more
20 Aug 2012 07:20

Proteome Sciences reports collaboration research agreement

Biotech group Proteome Sciences has agreed to work with CHDI Foundation Inc on a systems biology project regarding Huntington's disease. Initially, Proteome will provide its PS Biomarker Services protein profiling to CHDI's research programmes. The analyses will be performed at Proteome's facility

Read more
5 Apr 2012 11:50

Proteome issues new licence for stroke product

Pharma group Proteome Sciences has granted a non-exclusive licence to UK firm Randox Laboratories for its portfolio of stroke biomarkers. Under the terms of the agreement Randox will develop products for early diagnosis of stroke and subsequent monitoring of treatment outcomes. Proteome will ear

Read more
28 Mar 2012 10:46

Proteome rockets on Alzheimer's blood test

Pharma group Proteome Sciences has had a strong morning on the markets after announcing success in its project to develop better diagnostic tools for Alzheimer's disease. A study of 1,000 patients has shown three distinct "biomarkers" in people's blood which can discriminate between mild "cognitive

Read more
19 Mar 2012 10:17

Stroke consortium to get €11m grant

Shares in biomarker specialist Proteome Sciences rose almost 5% on Monday morning after it announced the EU was to award €11m to a consortium of which it is a member. Euro-HYP-1, a consortium of academic, clinical and industrial European partners that includes Proteome, has been awarded the grant f

Read more
27 May 2011 12:09

Proteome boosted by Sanofi settlement

Biomarker specialist Proteome Sciences is back in profit after receiving €11m from Sanofi-Aventis to settle a warranty claim. The company posted pre-tax profits of £4.59m in the year to the end of December, including the warranty claim. This compared £4.20m pre-tax loss in 2009. Revenues for 2010

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.